+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hormone Replacement Therapy Market by Therapy Type, Route of Administration, End User, Distribution Channel, Gender, Age Group - Global Forecast to 2030- Product Image
Hormone Replacement Therapy Market by Therapy Type, Route of Administration, End User, Distribution Channel, Gender, Age Group - Global Forecast to 2030- Product Image
Sale

Hormone Replacement Therapy Market by Therapy Type, Route of Administration, End User, Distribution Channel, Gender, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905134
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hormone Replacement Therapy Market grew from USD 28.04 billion in 2024 to USD 30.52 billion in 2025. It is expected to continue growing at a CAGR of 8.69%, reaching USD 46.25 billion by 2030.

Market Introduction and Scope of Hormone Replacement Therapy

Hormone replacement therapy (HRT) has emerged as a cornerstone in managing age-related endocrine shifts and improving quality of life for patients experiencing hormonal deficiencies. As the field advances from traditional estrogen-only regimens to multifaceted combination protocols, clinicians and industry stakeholders are seeking a comprehensive perspective on evolving treatment paradigms and market dynamics. This executive summary sets the stage by outlining the scope of the HRT market, highlighting the breadth of therapeutic modalities and underscoring the strategic importance of staying attuned to emerging clinical practices and regulatory developments.

The introduction contextualizes HRT within broader health-care objectives, demonstrating how clinicians balance efficacy, safety and patient preferences. It also underscores evolving demographic trends and the growing prevalence of symptomatic hormonal decline across gender and age groups. By framing the discussion around patient-centered outcomes, regulatory changes and technological advancements in drug delivery, this section establishes a foundational understanding of why hormone replacement therapy continues to command significant attention from medical specialists, payers and manufacturers alike.

Transformative Shifts Reshaping the Hormone Therapy Market

The hormone replacement therapy landscape has undergone transformative shifts driven by innovation in molecular formulations, delivery mechanisms and personalized medicine approaches. Recent years have seen the emergence of bioidentical hormone therapies, which offer more precise endocrine mimicry and reduced side effect profiles compared to conventional analogs. Concurrently, advancements in transdermal and injectable delivery systems have enhanced patient adherence, reduced hepatic first-pass metabolism concerns and allowed for customizable dosing schedules.

These scientific breakthroughs coincide with a growing emphasis on real-world evidence and patient-reported outcomes. Health systems now prioritize longitudinal tracking of symptom relief and quality-of-life metrics, fueling iterative improvements in HRT regimens. Meanwhile, digital health technologies such as telemedicine platforms and wearable hormone monitoring devices are streamlining the patient journey from diagnosis to maintenance therapy. Taken together, these transformative shifts underscore a market that is rapidly evolving from one-size-fits-all protocols toward highly individualized treatment pathways underpinned by data analytics and patient engagement tools.

Evaluating the 2025 US Tariffs on Hormone Replacement Therapy

The introduction of updated United States tariffs in 2025 has imparted a notable influence on the hormone replacement therapy sector. Import duties on raw hormone precursors and finished pharmaceutical forms have increased procurement costs for manufacturers reliant on international supply chains. In response, several key players have begun to optimize sourcing strategies by renegotiating supplier contracts and seeking alternative raw material suppliers in jurisdictions with more favorable trade agreements.

Pricing pressures have reverberated across contract negotiations with health-care providers and reimbursement discussions with payers. Some manufacturers have responded by implementing tiered pricing frameworks to preserve market share among cost-sensitive segments while protecting margins in premium therapy categories. Regulatory agencies have also taken note, streamlining import licensing procedures for critical hormone compounds to mitigate potential shortages. As the market adapts to the new tariff environment, the balance between supply stability, cost management and patient access remains central to strategic decision-making in 2025.

Insights from Key Segmentation in HRT Offerings

A multidimensional segmentation framework reveals nuanced insights across therapy type, route of administration, end user, distribution channel, gender and age group. When evaluating therapy type, the market encompasses combination therapy, estrogen therapy, progesterone therapy and testosterone therapy, with combination regimens further subdivided into injectable, oral, topical and transdermal formats. Estrogen protocols span injectable, oral, topical and transdermal offerings, while progesterone solutions include injectable, oral and topical modalities. Testosterone approaches are available in injectable, oral and transdermal delivery.

Examining route of administration highlights injectable methods, divided into intramuscular and subcutaneous techniques, alongside oral presentations in liquid and tablet form. Topical applications consist of creams and lotions, whereas transdermal systems leverage gels and patches to ensure steady hormone release. End user segmentation spans homecare settings, hospitals and specialty clinics, each presenting distinct clinical and logistical considerations. Distribution channels encompass hospital pharmacies, online pharmacies and retail pharmacies, reflecting shifts in patient purchasing preferences and the growing influence of digital marketplaces.

Gender-based analysis underscores differing adoption rates and dosage requirements among female and male cohorts. Age group classification distinguishes patients under 50 years, those aged 50 to 59 and individuals 60 and above, illuminating how symptom profiles and treatment objectives evolve throughout the lifespan. This comprehensive segmentation matrix informs targeted product development, marketing strategies and clinical trial design, enabling stakeholders to align offerings with the precise needs of diverse patient populations.

Regional Dynamics Shaping Global HRT Trends

Regional dynamics are central to understanding global hormone replacement therapy adoption. The Americas lead with robust clinical trial pipelines, strong reimbursement frameworks and well-established specialty clinic networks that facilitate rapid uptake of innovative delivery systems. North America in particular benefits from favorable regulatory pathways and high patient awareness, reinforcing its position as a primary growth engine.

In Europe, Middle East & Africa, heterogeneity in health-care funding models and regulatory complexity shape market trajectories. Western Europe demonstrates steady demand for bioidentical therapies, while emerging economies in the Middle East and Africa exhibit nascent adoption constrained by limited infrastructure and affordability challenges. Policymakers and private-sector partners are collaborating to expand access through public-private partnerships and regional manufacturing initiatives.

Asia-Pacific represents a dynamic landscape characterized by rising per-capita health-care expenditure, expanding specialty clinics and an increasing focus on women’s health. Markets such as China, Japan and Australia are accelerating approvals for novel hormone formulations, while Southeast Asian nations are building capacity for locally manufactured generics. These regional nuances underscore the importance of adaptive strategies that align with regulatory environments, distribution ecosystems and evolving patient preferences across geographies.

Leading Companies Driving HRT Innovations

The competitive landscape in hormone replacement therapy features both established pharmaceutical giants and agile specialty players driving product innovation and patient engagement. Multinational corporations leverage extensive R&D budgets to develop next-generation bioidentical hormones and advanced delivery platforms, often securing exclusive partnerships with technology providers and academic research institutions.

Regional and niche manufacturers are differentiating through localized clinical studies, cost-effective manufacturing processes and tailored marketing strategies for underserved segments. Collaborative alliances between contract manufacturing organizations and biotech startups are accelerating time-to-market for proprietary formulations. At the same time, key players are expanding their portfolios via mergers and acquisitions, enhancing their foothold in strategic markets and broadening therapeutic offerings beyond traditional estrogen and progesterone combinations. Collectively, these dynamics reflect a marketplace in which innovation, agility and strategic partnerships determine the leaders in the evolving HRT arena.

Actionable Strategies for Industry Stakeholders

Industry leaders can capitalize on emerging opportunities by adopting a multifaceted strategy focused on personalization, collaboration and operational excellence. First, enhancing patient-centric care through bespoke hormone formulations and digital adherence tools will strengthen brand loyalty and clinical outcomes. Integrating telehealth platforms and remote monitoring solutions into therapy programs can optimize dosing regimens in real time and differentiate service offerings.

Second, forging strategic partnerships with raw material suppliers, contract manufacturers and technology providers will mitigate supply chain risks and accelerate product development timelines. Co-developing proprietary delivery systems in collaboration with device innovators will secure competitive advantages in transdermal and injectable administration.

Third, engaging with payers and health authorities to establish value-based reimbursement models will ensure favorable coverage for novel therapies. Generating robust real-world evidence to demonstrate cost-effectiveness and quality-of-life improvements will underpin these discussions. Finally, maintaining operational excellence through continuous process optimization and lean manufacturing practices will preserve margins in the face of tariff-driven cost pressures. By implementing these strategic levers, organizations can achieve sustained growth and market leadership.

Transparent Research Framework for HRT Analysis

This analysis draws upon a rigorous research framework combining primary interviews with endocrinologists, pharmacists and payers, secondary data from peer-reviewed journals and regulatory agency publications, and real-world evidence from patient registries. A thorough competitive benchmarking process assessed product portfolios, pipeline assets and strategic initiatives of leading market participants. Supply chain mapping was conducted to identify key raw material sources and manufacturing hubs, while tariff schedules and trade agreements were reviewed to evaluate cost implications.

Segmentation analysis leveraged structured data clustering to categorize therapy types, administration routes, end users, distribution channels, gender and age cohorts. Regional market sizing and adoption trends were synthesized from national health-care databases and in-country expert consultations. Finally, thematic validation workshops with cross-functional stakeholders ensured that strategic recommendations were grounded in market realities and actionable in diverse organizational contexts.

Final Thoughts on the Future of Hormone Therapy

In summary, the hormone replacement therapy market stands at an inflection point defined by scientific breakthroughs, evolving patient expectations and shifting regulatory landscapes. From the advent of bioidentical hormone formulations to the strategic responses required by new tariff regimes, stakeholders must navigate a complex environment that demands agility and informed decision-making.

Rigorous segmentation and regional analysis reveal tailored pathways for growth, while insights into competitive positioning and supply chain considerations highlight where value can be captured. By embracing digital health integrations, strategic partnerships and evidence-driven reimbursement strategies, industry participants can optimize patient outcomes and secure sustainable competitive advantages. The future trajectory of HRT will be shaped by those who proactively adapt to these transformative forces and place the patient journey at the forefront of therapeutic innovation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapy Type
    • Combination Therapy
      • Injectable Combination
      • Oral Combination
      • Topical Combination
      • Transdermal Combination
    • Estrogen Therapy
      • Injectable Estrogen
      • Oral Estrogen
      • Topical Estrogen
      • Transdermal Estrogen
    • Progesterone Therapy
      • Injectable Progesterone
      • Oral Progesterone
      • Topical Progesterone
    • Testosterone Therapy
      • Injectable Testosterone
      • Oral Testosterone
      • Transdermal Testosterone
  • Route Of Administration
    • Injectable
      • Intramuscular
      • Subcutaneous
    • Oral
      • Liquid
      • Tablets
    • Topical
      • Cream
      • Lotion
    • Transdermal
      • Gel
      • Patch
  • End User
    • Homecare Settings
    • Hospitals
    • Specialty Clinics
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Gender
    • Female
    • Male
  • Age Group
    • 50 To 59
    • 60 And Above
    • Under 50
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • AbbVie Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Bayer AG
  • Gedeon Richter Plc
  • Ferring Pharmaceuticals Inc.
  • Endo International plc
  • Teva Pharmaceuticals Industries Ltd.
  • GlaxoSmithKline plc

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hormone Replacement Therapy Market, by Therapy Type
8.1. Introduction
8.2. Combination Therapy
8.2.1. Injectable Combination
8.2.2. Oral Combination
8.2.3. Topical Combination
8.2.4. Transdermal Combination
8.3. Estrogen Therapy
8.3.1. Injectable Estrogen
8.3.2. Oral Estrogen
8.3.3. Topical Estrogen
8.3.4. Transdermal Estrogen
8.4. Progesterone Therapy
8.4.1. Injectable Progesterone
8.4.2. Oral Progesterone
8.4.3. Topical Progesterone
8.5. Testosterone Therapy
8.5.1. Injectable Testosterone
8.5.2. Oral Testosterone
8.5.3. Transdermal Testosterone
9. Hormone Replacement Therapy Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Subcutaneous
9.3. Oral
9.3.1. Liquid
9.3.2. Tablets
9.4. Topical
9.4.1. Cream
9.4.2. Lotion
9.5. Transdermal
9.5.1. Gel
9.5.2. Patch
10. Hormone Replacement Therapy Market, by End User
10.1. Introduction
10.2. Homecare Settings
10.3. Hospitals
10.4. Specialty Clinics
11. Hormone Replacement Therapy Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Hormone Replacement Therapy Market, by Gender
12.1. Introduction
12.2. Female
12.3. Male
13. Hormone Replacement Therapy Market, by Age Group
13.1. Introduction
13.2. 50 to 59
13.3. 60 and Above
13.4. Under 50
14. Americas Hormone Replacement Therapy Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Hormone Replacement Therapy Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Hormone Replacement Therapy Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Pfizer Inc.
17.3.3. Merck & Co., Inc.
17.3.4. Novo Nordisk a/S
17.3.5. Bayer AG
17.3.6. Gedeon Richter Plc
17.3.7. Ferring Pharmaceuticals Inc.
17.3.8. Endo International plc
17.3.9. Teva Pharmaceuticals Industries Ltd.
17.3.10. GlaxoSmithKline plc
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HORMONE REPLACEMENT THERAPY MARKET MULTI-CURRENCY
FIGURE 2. HORMONE REPLACEMENT THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. HORMONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. HORMONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. HORMONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HORMONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY 50 TO 59, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY 60 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY UNDER 50, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 93. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 94. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 95. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 96. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 98. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 99. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 100. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 101. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 104. CANADA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 107. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 108. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 113. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 114. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 118. MEXICO HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 176. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 178. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 179. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 180. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 181. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 184. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 185. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 189. GERMANY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 191. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 192. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 193. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 194. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 195. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 197. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 198. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 199. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 200. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 218. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 219. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 220. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 221. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 222. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 223. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 225. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 226. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 227. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 228. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 231. ITALY HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 233. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 234. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 235. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 236. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 237. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 239. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 240. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 241. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 245. SPAIN HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 289. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 290. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 291. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 292. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 293. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 295. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 296. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 297. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 298. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 301. DENMARK HORMONE REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ESTROGEN THERAPY, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY PROGESTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE THERAPY, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS HORMONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
T

Companies Mentioned

The companies profiled in this Hormone Replacement Therapy market report include:
  • AbbVie Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Bayer AG
  • Gedeon Richter Plc
  • Ferring Pharmaceuticals Inc.
  • Endo International plc
  • Teva Pharmaceuticals Industries Ltd.
  • GlaxoSmithKline plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 30.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 46.25 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Menopause Market by Product Type, Stage of Menopause, Route of Administration, Distribution Channel - Global Forecast to 2030 - Product Image

Menopause Market by Product Type, Stage of Menopause, Route of Administration, Distribution Channel - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033 - Product Image

Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Hormone Replacement Therapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Hormone Replacement Therapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 135 Pages
  • Global
From

About the Hormone Replacement Therapy Market

Hormone Replacement Therapy (HRT) is a form of treatment used to address the symptoms of menopause in women. It involves the administration of hormones, such as estrogen and progesterone, to replace the hormones that the body is no longer producing. HRT is used to reduce the symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness, as well as to reduce the risk of osteoporosis and other health conditions. HRT is also used to treat other conditions, such as endometriosis and polycystic ovary syndrome. HRT is available in a variety of forms, including oral tablets, patches, gels, and creams. The type of HRT prescribed will depend on the individual's medical history and the severity of their symptoms. Some companies in the HRT market include Pfizer, Merck, Novo Nordisk, and AbbVie. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.